CSL have an interesting test by the end of March. There is an initial DMC futility review of their CSL112.
The very large Phase IiB n>1000 was less than spectacular in terms of efficacy. Endpoints were not powered for efficacy however CSL are confident on the MOA.
CSL112 is a potential indirect threat tor Revascor (or whatever it is called these days) in that it is meant to reduce those that' go on to CHF due to coronary artery disease.
- Forums
- ASX - By Stock
- MSB
- MSB Trading - 2020
MSB Trading - 2020, page-1041
-
-
- There are more pages in this discussion • 22,120 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.5¢ |
Change
0.015(1.56%) |
Mkt cap ! $1.118B |
Open | High | Low | Value | Volume |
97.0¢ | 99.5¢ | 97.0¢ | $1.039M | 1.060M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 134053 | 97.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.0¢ | 20249 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 63027 | 0.970 |
11 | 234321 | 0.965 |
12 | 111781 | 0.960 |
7 | 140234 | 0.955 |
9 | 568040 | 0.950 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 42015 | 24 |
0.980 | 102591 | 16 |
0.985 | 36884 | 11 |
0.990 | 112245 | 10 |
0.995 | 80259 | 9 |
Last trade - 11.09am 22/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |